Can blood eosinophil count be used as a predictive marker for the severity of COPD and concomitant cardiovascular...

Area of Science:

• Pulmonary Medicine
• Cardiology
• Hematology

Background:

• Chronic obstructive pulmonary disease (COPD) is a significant global health issue.
• Cardiovascular disease (CVD) frequently coexists with COPD, increasing patient morbidity and mortality.
• Eosinophils, a type of white blood cell, have been implicated in inflammatory processes relevant to both COPD and CVD.

Purpose of the Study:

• To investigate the association between eosinophil count and the presence of CVD in COPD patients.
• To explore the correlation between eosinophil count and the risk of exacerbations in COPD.
• To identify potential biomarkers for cardiovascular risk in COPD management.

Main Methods:

• A cohort of 405 COPD patients was analyzed, categorized by Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages E, A, and B.
• Routine blood tests, including leukocyte and differential counts, were performed using an automated hematology analyzer.
• Statistical analysis was employed to compare eosinophil levels between groups with and without CVD and varying exacerbation risks.

Main Results:

• COPD patients with concurrent CVD exhibited significantly higher eosinophil counts and percentages compared to those without CVD.
• The prevalence of CVD was elevated in GOLD E patients, who also had higher eosinophil counts.
• While eosinophil count was higher in GOLD E patients with exacerbations, eosinophil percentage did not show a significant difference.

Conclusions:

• A strong relationship exists between eosinophil levels and cardiovascular events in COPD patients.
• Eosinophil count may serve as a valuable indicator of cardiovascular risk, especially in COPD patients prone to exacerbations.
• Further research is warranted to elucidate the precise mechanisms linking eosinophils, COPD, and CVD.